Healthcare provider profile · identity verified

Mark D Vogt, D.O.

Emergency Medicine · CLINTON, MO · NPI 1194792341

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Pantoprazole Sodium	Pantoprazole Sodium	448	97
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	332	68
Lisinopril	Lisinopril	273	60
Rosuvastatin Calcium	Rosuvastatin Calcium	265	47
Atorvastatin Calcium	Atorvastatin Calcium	252	57
Alprazolam	Alprazolam	240	39
Amlodipine Besylate	Amlodipine Besylate	234	49
Tamsulosin Hcl	Tamsulosin Hcl	210	47
Levothyroxine Sodium	Levothyroxine Sodium	203	42
Metformin Hcl	Metformin Hcl	203	40
Tramadol Hcl	Tramadol Hcl	194	41
Albuterol Sulfate Hfa	Albuterol Sulfate	190	39
Eliquis	Apixaban	186	25
Furosemide	Furosemide	162	36
Losartan Potassium	Losartan Potassium	158	41
Metoprolol Tartrate	Metoprolol Tartrate	155	35
Simvastatin	Simvastatin	148	33
Lorazepam	Lorazepam	139	26
Potassium Chloride	Potassium Chloride	139	31
Hydrochlorothiazide	Hydrochlorothiazide	131	27
Omeprazole	Omeprazole	129	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	120	18
Gabapentin	Gabapentin	115	32
Glipizide	Glipizide	115	25
Meloxicam	Meloxicam	109	22
Metoprolol Succinate	Metoprolol Succinate	108	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	105	22
Zolpidem Tartrate	Zolpidem Tartrate	102	24
Pravastatin Sodium	Pravastatin Sodium	99	24
Carvedilol	Carvedilol	85	15
Prednisone	Prednisone	80	31
Citalopram Hbr	Citalopram Hydrobromide	74	14
Fluoxetine Hcl	Fluoxetine Hcl	73	14
Allopurinol	Allopurinol	65	16
Ibuprofen	Ibuprofen	65	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	64	40
Duloxetine Hcl	Duloxetine Hcl	59	suppressed
Jardiance	Empagliflozin	56	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	suppressed
Clopidogrel	Clopidogrel Bisulfate	53	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Spironolactone	Spironolactone	50	suppressed
Alendronate Sodium	Alendronate Sodium	49	suppressed
Clonazepam	Clonazepam	48	suppressed
Farxiga	Dapagliflozin Propanediol	47	suppressed
Pregabalin	Pregabalin	47	suppressed
Diclofenac Sodium	Diclofenac Sodium	45	suppressed
Famotidine	Famotidine	45	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	44	suppressed
Ozempic	Semaglutide	43	suppressed
Sertraline Hcl	Sertraline Hcl	43	suppressed
Methylprednisolone	Methylprednisolone	42	31
Doxycycline Hyclate	Doxycycline Hyclate	40	18
Celecoxib	Celecoxib	39	suppressed
Finasteride	Finasteride	39	13
Symbicort	Budesonide/Formoterol Fumarate	39	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Temazepam	Temazepam	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Trazodone Hcl	Trazodone Hcl	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	suppressed
Ondansetron Odt	Ondansetron	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Diazepam	Diazepam	30	suppressed
Risperidone	Risperidone	30	suppressed
Naproxen	Naproxen	29	suppressed
Fluconazole	Fluconazole	28	suppressed
Nystatin	Nystatin	28	12
Carisoprodol	Carisoprodol	27	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Torsemide	Torsemide	27	suppressed
Linzess	Linaclotide	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Glimepiride	Glimepiride	25	suppressed
Azithromycin	Azithromycin	24	17
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	12
Terazosin Hcl	Terazosin Hcl	22	suppressed
Clindamycin Hcl	Clindamycin Hcl	21	13
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	19	suppressed
Colestipol Hcl	Colestipol Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Estradiol	Estradiol	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Glyburide	Glyburide	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Cephalexin	Cephalexin	16	16
Donepezil Hcl	Donepezil Hcl	16	suppressed
Metronidazole	Metronidazole	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	11
Dutasteride	Dutasteride	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Anastrozole	Anastrozole	13	suppressed
Balsalazide Disodium	Balsalazide Disodium	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Digoxin	Digoxin	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Valsartan	Valsartan	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	11	suppressed
Primidone	Primidone	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error